Epidemiology of isotretinoin exposure during pregnancy
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background Exposure to isotretinoin during pregnancy is associated with a high risk of major fetal malformations. Objective Our purpose was to determine the reasons for and outcomes of in utero isotretinoin exposure. Methods On the basis of 433 spontaneous reports, we describe the likely reasons these exposures occurred and the outcomes of these pregnancies. In our analysis of the outcomes of pregnancy, we separately consider the pregnancies known to us before their outcomes were determined as prospective cases. Results Timing of conception in relation to initiation of therapy with isotretinoin was known for 396 women. Of these, 130 patients (33%) were already pregnant when they started isotretinoin. An additional 65 patients (16%) became pregnant in the first 3 weeks of isotretinoin use. Pregnancy outcomes were known on 409 pregnancies. Among these, 222 (54%) ended in elective abortion and 29 (7%) in spontaneous or missed abortion. Of 151 births, 72 (48%) were normal, 71 (47%) had congenital malformations, and 8 (5%) had abnormalities other than malformations. Of 94 prospectively ascertained pregnancies that ended in births, 28% had congenital malformations (95% confidence interval 19% to 37%). Exposure to isotretinoin during any time and for as little as one capsule within the first trimester have been associated with congenital malformations. Conclusion The high proportion of exposures in already or recently pregnant women illustrates the importance of obtaining a negative…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After introduction of isotretinoin in the US in 1982, there were hundreds of reports of isotretinoinexposed pregnancies that resulted in fetal congenital malformations.”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [275]
Citations
Cites
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Lott, I. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131401 · Cited by 1,942
Lenton, E. A., Neal, L. M., & Sulaiman, R. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46337-5 · Cited by 170
The Isotretinoin Teratogen Syndrome
Benke, P. J. (1984) · JAMA · doi:10.1001/jama.1984.03340480049027 · Cited by 124
(1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-78-3-466_2 · Cited by 122
Stern, R. S., Rosa, F., & Baum, C. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80142-5 · Cited by 121
Self-citationEstimates of pregnancies and pregnancy rates for the United States, 1976-85.
Ventura, S. J., Taffel, S. M., & Mosher, W. D. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.5.506 · Cited by 27
ISOTRETINOIN DOSE AND TERATOGENICITY
Lammer, E. J., Schunior, A., Hayes, A. M., & Holmes, L. B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90143-2 · Cited by 18
From the Food and Drug Administration
Nightingale, S. L. (1988) · JAMA · doi:10.1001/jama.1988.03410030025008 · Cited by 3
Research works printed but not linked: 4
- 1983, Adverse effects with isotretinoin, FDA Drug Bull, 13, 2123
- 1984, Update on birth defects with isotretinoin, FDA Drug Bull, 14, 15
- Lammer, 1988, Unusual high risk for adverse outcomes of pregnancy following fetal isotretinoin exposure [Abstract], Am J Hum Genet, 43, A58
- Mitchell, 1990, Accutane exposure in pregnancy—a novel survey design [Abstract], Teratology, 41, 578
Cited by
Guidelines of care for the management of acne vulgaris
Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.037 · Cited by 1,597
“After introduction of isotretinoin in the United States in 1982, there were hundreds of reports of isotretinoinexposed pregnancies within just several years, resulting in a high rate of congenital malformations.(302) Because of this, the first risk management program was implemented.”
BackgroundGuidelines of care for acne vulgaris management
Strauss, J. S., Krowchuk, D. P., Leyden, J. J., Lucky, A. W., Shalita, A. R., Siegfried, E. C., Thiboutot, D. M., Van Voorhees, A. S., Beutner, K. A., Sieck, C. K., et al. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.048 · Cited by 552
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
A Pregnancy-Prevention Program in Women of Childbearing Age Receiving Isotretinoin
Mitchell, A. A., Van Bennekom, C. M., & Louik, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330206 · Cited by 177
Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin
Rademaker, M. (2010) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2010.00657.x · Cited by 162
“Teratogenicity is arguably the most significant, with estimates of 40% of exposed pregnancies associated with significant birth defects.(14) Both cases of pregnancy in this study had been prescribed oral contraceptives, and were considered oral contraceptive failures.”
Background
Metadata
- Authors
- Dai, W. S., LaBraico, J. M., & Stern, R. S.
- Affiliations
- Harvard University (US)
- Corresponding author
- Dai, Wanju S.
- ORCID
- Stern, Robert S.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 1992-04
- Volume
- 26
- Issue
- 4
- Pages
- 599-606
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2107996839
- Semantic Scholar
- c9eb0ba4aad2326fd718c707cdb6fe46292cd7e4
- Cited by
- 133
- References
- 8
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 2 · 2012: 10
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of the American Academy of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- isotretinoin, pregnancy, teratogenicity, congenital malformations, fetal malformations, conception timing, pregnancy testing, contraception, acne treatment, miscarriage, missed abortion
- MeSH terms
- Abnormalities, Drug-Induced, Abortion, Spontaneous, Abortion, Induced, Adolescent, Adult, Contraception Behavior, Female, Humans, Pregnancy, Pregnancy Outcome, Prospective Studies, Retrospective Studies, Isotretinoin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology of isotretinoin exposure during pregnancy. https://app.cochat.ai/papers/10.1016/0190-9622(92)70088-w
- The paper
- Dai, W. S., LaBraico, J. M., & Stern, R. S. (1992). Epidemiology of isotretinoin exposure during pregnancy. Journal of the American Academy of Dermatology. https://doi.org/10.1016/0190-9622(92)70088-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.